- IP to Startups
- Biomedical Research Cores
John is a medicinal chemist with a bachelor's degree in biochemistry from the University of Pennsylvania. He has nine years of medicinal chemistry experience, during seven of which he worked on kinase targets at a medium sized biotech, primarily on an MST1 inhibitor program for the treatment of autoimmune disease. For the last two years, John has been in the Molecular Design and Synthesis group of Rutgers Translational Sciences, where he has worked on a number of programs in collaboration with the Cancer Institute of New Jersey (CINJ). The majority of his time has been focused on designing zinc metallochaperones to be used in the reactivation of mutant forms of p53 commonly found in cancers.